What Happened?
Shares of health coverage company Centene (NYSE: CNC) fell 7.5% in the afternoon session after a peer in the health insurance industry, Molina Healthcare, cut its annual profit forecast after reporting higher-than-expected medical costs. Molina's announcement triggered a sell-off in its stock and created a ripple effect across the sector. The company slashed its earnings guidance, citing elevated medical expenses, particularly in its government-backed Affordable Care Act plans. This news raised concerns among investors that Centene, which operates in a similar market, could face the same financial pressures. As a result, the negative sentiment dragged down shares of several other health insurers as the market reacted to signs of trouble in the sector.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Centene? Access our full analysis report here.
What Is The Market Telling Us
Centene’s shares are quite volatile and have had 17 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 13 days ago when the stock dropped 4.1% on the news that worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling a meeting with President Xi caused a rapid sell-off in the market. The trade dispute flared up after China imposed export controls on rare earth minerals, which are critical components for high-tech manufacturing. The escalation of the trade war raises concerns about supply chain disruptions and increased costs for technology companies, which are heavily reliant on global trade, leading to a broad sell-off in the sector.
Centene is down 44.3% since the beginning of the year, and at $33.69 per share, it is trading 48.9% below its 52-week high of $65.89 from January 2025. Investors who bought $1,000 worth of Centene’s shares 5 years ago would now be looking at an investment worth $499.70.
Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
